Primary OsteoarthritisCartilage DegenerationOsteoarthritis, HipInflammatory ArthritisOsteonecrosis of Femoral HeadTraumatic Disorder
Investigational drug(s) / intervention(s)
Primary hip replacement with cementless stem
Primary hip replacement with cementless stem: Total Hip Arthroplasty is today one of the most established surgical orthopaedic procedures worldwide.
Study summary
The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.
Eligibility
Sex
ALL
Min age
35 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria:
* Unilateral hip osteoarthritis
* Indication for CoreHip Standard hip stem according to preoperative planning
* Written Informed Consent
* Age 35-85 years
* According to the assessment of the study doctor, the patient is therapy compliant and able to attend the follow-up visits
Exclusion Criteria:
* Femoral neck fractures
* Pregnancy
* BMI \> 35
* History of femoral fracture or previous surgery on the same hip
* Metabolic bone disease, use of steroids or other drugs affecting bone metabolism
* Intraoperative bone cracks
* Severe osteoarthritis of the contralateral hip
* THA of the contralateral side or other event leading to restricted weight bearing during the study period
Primary outcome measure(s)
Radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) — within 24 months postoperative Changes in bone mineral density (BMD) according to Gruen.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.